Cytek Holds 2026 Revenue Forecast at $205M-$212M After Q1 Growth
CTKB reports Q1 2026 revenue of $44.1 million, up 6% year-over-year, as U.S. demand stabilizes. Cytek Biosciences reaffirmed its full-year 2026 revenue outlook of $205 million to $212 million after reporting Q1 2026 revenue of $44.1 million. The figure marks a 6% increase